Crossmark

Reply to the letter to the editor about “recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Lundgren and Radros

Crossref DOI link: https://doi.org/10.1007/s00345-025-05526-3

Published Online: 2025-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rosenblad, Andreas Karlsson https://orcid.org/0000-0003-3691-8326
Hashim, Bassam Mazin https://orcid.org/0009-0006-8775-9774
Lindblad, Per https://orcid.org/0000-0003-1217-4289
Ljungberg, Börje https://orcid.org/0000-0002-4121-3753
License Information

Text and Data Mining valid from 2025-03-10

Version of Record valid from 2025-03-10
More Information

Article History

Received: 17 February 2025

Accepted: 21 February 2025

First Online: 10 March 2025

Declarations

:

: The authors declare no competing interests.